2.15 USD
↘ 0.14 (6.11%)AT CLOSE (11:59 AM EDT)
Acumen Pharmaceuticals, Inc. Common Stock
ABOSNASDAQ • USD
2.15
↘ 0.01 (0.23%)
POST MARKET (AS OF 04:32 PM EDT)
Post Market
AS OF 04:32 PM EDT
2.15
↘ 0.01 (0.23%)
Market: CLOSED
Open?$2.29
High?$2.30
Low?$2.12
Prev. Close?$2.29
Volume?319.6K
Avg. Volume?313.8K
VWAP?$2.18
Rel. Volume?1.02x
Bid / Ask
Bid?$1.84 × 100
Ask?$2.48 × 100
Spread?$0.64
Midpoint?$2.16
Valuation & Ratios
Market Cap?165.4M
Shares Out?72.2M
Float?31.2M
Float %?51.4%
P/E Ratio?N/A
P/B Ratio?1.89
EPS?-$1.57
Dividend?0.00%
Ex-Dividend?N/A
Shares of Acumen Pharmaceuticals, Inc. Common Stock (ABOS) are trading at $2.14. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest ABOS is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Employees
61
Market Cap
165.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-01
Address
1210-1220 WASHINGTON STREET
NEWTON, MA 02465
Phone: 617-344-4190
NEWTON, MA 02465
Phone: 617-344-4190
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?42
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.64Distress
Confidence?41%Low
Short InterestHigh
Short % of Float?5.61%Elevated
Short Interest?1.7M
Days to Cover?6.4
Free Float31.2M
Avg Daily Volume273.5K
Settlement Date2026-05-15
Financial Health
Current Ratio?4.55Strong
Quick Ratio?4.55Strong
Cash Ratio?1.77Strong
Debt/Equity?0.35Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.89CHEAP▾
Peers100
S&P77
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-129.5%WEAK▾
S&P3
ROA?-84.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-105554000
Enterprise Value?$144.7M
Fundamentals ratios updated end of day